
Zhejiang Orient Gene Biotech Co., Ltd.
SSE:688298.SS
26.98 (CNY) • At close June 11, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 191.952 | 170.302 | 239.379 | 233.398 | 181.748 | 158.561 | 150.628 | 125.499 | 376.045 | 910.179 | 746.518 | 2,365.015 | 4,746.226 | 2,768.467 | 1,018.719 | 4,146.126 | 2,235.856 | 2,164.687 | 272.518 | 717.787 | 110.363 | 105.143 | 92.547 | 90.41 | 79.276 | 80.729 |
Cost of Revenue
| 139.434 | 135.65 | 160.179 | 190.676 | 123.746 | 105.75 | 86.322 | 70.704 | 252.96 | 821.616 | 466.337 | 1,297.615 | 1,728.83 | 964.234 | 332.715 | 816.507 | 551.869 | 491.041 | 44.076 | 102.094 | 40.568 | 53.884 | 48.709 | 46.793 | 43.468 | 41.219 |
Gross Profit
| 52.518 | 34.652 | 79.2 | 42.722 | 58.002 | 52.812 | 64.306 | 54.795 | 123.086 | 88.563 | 280.181 | 1,067.4 | 3,017.396 | 1,804.233 | 686.004 | 3,329.619 | 1,683.987 | 1,673.647 | 228.443 | 615.693 | 69.796 | 51.259 | 43.838 | 43.617 | 35.809 | 39.51 |
Gross Profit Ratio
| 0.274 | 0.203 | 0.331 | 0.183 | 0.319 | 0.333 | 0.427 | 0.437 | 0.327 | 0.097 | 0.375 | 0.451 | 0.636 | 0.652 | 0.673 | 0.803 | 0.753 | 0.773 | 0.838 | 0.858 | 0.632 | 0.488 | 0.474 | 0.482 | 0.452 | 0.489 |
Reseach & Development Expenses
| 58.726 | 0 | 63.579 | 71.646 | 71.965 | 70.641 | 64.396 | 71.835 | 51.905 | 111.329 | 52.627 | 242.511 | 105.097 | 185.495 | 47.341 | 172.385 | 23.3 | 52.338 | 14.711 | 18.829 | 7.872 | 8.362 | 8.425 | 8.078 | 6.891 | 4.778 |
General & Administrative Expenses
| 89.889 | 0 | 254.878 | -43.358 | 90.025 | -122.519 | 205.988 | -33.216 | 77.213 | -80.595 | 108.1 | 52.733 | 35.564 | -2.082 | 38.59 | 7.718 | 11.166 | -3.658 | 9.048 | 0.711 | 4.898 | -6.426 | 5.188 | 2.181 | 4.831 | -5.201 |
Selling & Marketing Expenses
| 44.144 | 0 | 80.48 | 37.767 | 34.733 | 45.113 | 40.814 | 36.052 | 40.213 | 10.29 | 39.509 | 129.036 | 306.277 | 350.408 | 89.443 | 307.035 | 291.976 | 264.101 | 16.448 | 29.358 | 7.491 | 8.776 | 6.913 | 6.466 | 6.64 | 7.51 |
SG&A
| 134.034 | -214.132 | 335.358 | 111.741 | 129.447 | 149.197 | 246.802 | 2.836 | 117.425 | -70.304 | 147.609 | 181.769 | 341.841 | 348.325 | 128.033 | 314.753 | 303.141 | 260.443 | 25.496 | 30.069 | 12.388 | 2.35 | 12.102 | 8.647 | 11.471 | 2.309 |
Other Expenses
| -16.755 | 464.457 | -196.975 | -5.774 | -3.251 | -220.438 | -0.288 | 34.695 | 2.478 | 158.679 | -18.398 | 56.118 | 23.477 | -0.623 | -1.391 | -4.442 | -0.002 | 0.453 | 0.074 | 0.691 | -0.143 | -0.035 | 0.024 | -1.497 | 1.771 | 1.19 |
Operating Expenses
| 176.004 | 330.937 | 201.962 | 189.16 | 204.662 | 440.275 | 196.559 | 184.011 | 171.809 | 199.704 | 181.838 | 480.398 | 470.415 | 592.443 | 173.022 | 516.688 | 339.394 | 341.273 | 45.893 | 56.594 | 19.509 | 22.693 | 19.07 | 19.191 | 19.106 | 17.6 |
Operating Income
| -123.486 | -283.291 | -122.762 | -146.438 | -146.66 | -387.464 | -105.169 | 62.177 | -48.723 | -1,167.067 | 401.848 | 782.768 | 2,510.661 | 1,160.358 | 620.685 | 2,617.98 | 1,377.376 | 1,201.74 | 166.838 | 552.226 | 53.542 | 25.632 | 28.083 | 25.27 | 12.048 | 19.816 |
Operating Income Ratio
| -0.643 | -1.663 | -0.513 | -0.627 | -0.807 | -2.444 | -0.698 | 0.495 | -0.13 | -1.282 | 0.538 | 0.331 | 0.529 | 0.419 | 0.609 | 0.631 | 0.616 | 0.555 | 0.612 | 0.769 | 0.485 | 0.244 | 0.303 | 0.28 | 0.152 | 0.245 |
Total Other Income Expenses Net
| -0.088 | -24.333 | 2.525 | 57.786 | 79.403 | 29.661 | -0.288 | 34.695 | 11.068 | -15.477 | -18.13 | -5.273 | -18.578 | -0.599 | -0.825 | -5.008 | -0.002 | -0.687 | 0.074 | 0.691 | -0.143 | -0.035 | 0.024 | -1.497 | 1.771 | 1.19 |
Income Before Tax
| -123.575 | -307.624 | -120.237 | -88.652 | -67.256 | -357.802 | -105.457 | 96.872 | -37.655 | -1,182.543 | 383.718 | 777.496 | 2,492.083 | 1,159.759 | 619.86 | 2,612.972 | 1,377.374 | 1,201.053 | 166.912 | 552.917 | 53.4 | 25.597 | 28.107 | 23.773 | 13.82 | 21.006 |
Income Before Tax Ratio
| -0.644 | -1.806 | -0.502 | -0.38 | -0.37 | -2.257 | -0.7 | 0.772 | -0.1 | -1.299 | 0.514 | 0.329 | 0.525 | 0.419 | 0.608 | 0.63 | 0.616 | 0.555 | 0.612 | 0.77 | 0.484 | 0.243 | 0.304 | 0.263 | 0.174 | 0.26 |
Income Tax Expense
| -2.805 | -13.847 | -6.054 | 0.756 | 1.838 | -6.984 | -0.244 | 12.512 | 8.758 | -193.614 | 73.851 | 99.668 | 393.417 | 143.47 | 95.561 | 399.003 | 191.285 | 184.934 | 26.962 | 74.317 | 7.737 | 3.226 | 4.152 | 3.966 | 2.446 | 3.51 |
Net Income
| -115.452 | -266.867 | -110.549 | -84.254 | -67.353 | -325.2 | -107.192 | 85.138 | -46.413 | -988.929 | 309.889 | 674.966 | 2,066.68 | 1,000.921 | 525.018 | 2,207.894 | 1,186.355 | 1,012.902 | 140.51 | 480.031 | 43.916 | 23.752 | 25.138 | 21.101 | 12.114 | 17.729 |
Net Income Ratio
| -0.601 | -1.567 | -0.462 | -0.361 | -0.371 | -2.051 | -0.712 | 0.678 | -0.123 | -1.087 | 0.415 | 0.285 | 0.435 | 0.362 | 0.515 | 0.533 | 0.531 | 0.468 | 0.516 | 0.669 | 0.398 | 0.226 | 0.272 | 0.233 | 0.153 | 0.22 |
EPS
| -0.57 | -1.28 | -0.57 | -0.43 | -0.33 | -1.61 | -0.55 | 0.51 | -0.23 | -5.89 | 2.58 | 5.62 | 12.3 | 4.96 | 4.38 | 18.41 | 5.89 | 8.43 | 0.7 | 4.04 | 0.22 | 0.26 | 0.17 | 0.23 | 0.077 | 0.19 |
EPS Diluted
| -0.57 | -1.28 | -0.57 | -0.43 | -0.33 | -1.61 | -0.53 | 0.51 | -0.23 | -5.89 | 2.58 | 5.62 | 12.3 | 4.96 | 4.38 | 18.41 | 5.89 | 8.43 | 0.7 | 4.04 | 0.22 | 0.26 | 0.17 | 0.23 | 0.077 | 0.19 |
EBITDA
| -119.752 | -283.291 | -116.165 | -91.507 | -8.822 | -332.175 | -43.641 | 136.797 | 1.849 | -1,150.079 | 343.063 | 779.162 | 2,505.449 | 1,160.247 | 620.075 | 2,645.986 | 1,381.944 | 1,203.418 | 166.913 | 552.917 | 55.633 | 27.431 | 30.155 | 25.718 | 14.378 | 21.972 |
EBITDA Ratio
| -0.624 | -1.663 | -0.485 | -0.392 | -0.049 | -2.095 | -0.29 | 1.09 | 0.005 | -1.264 | 0.46 | 0.329 | 0.528 | 0.419 | 0.609 | 0.638 | 0.618 | 0.556 | 0.612 | 0.77 | 0.504 | 0.261 | 0.326 | 0.284 | 0.181 | 0.272 |